Trials / Completed
CompletedNCT03775447
Fox BioNet Project: ECV-003
FoxBioNet: ECV (Extracellular Vesicle) 003
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 38 (actual)
- Sponsor
- Michael J. Fox Foundation for Parkinson's Research · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to optimize pre-analytical cerebrospinal fluid (CSF) extracellular vesicle isolation protocols for increasing the detection of LRRK2 activity in human CSF
Detailed description
Specific aims to accomplish this objective are: PRIMARY OBJECTIVES: * To evaluate a series of extracellular vesicle isolation methods for their ability to enrich for LRRK2 and increase the detection of LRRK2 in CSF samples. * To compare the measurements of LRRK2, p1292 LRRK2, Rabs and pRabs from the ECVs isolated using each method. * To assess the inter-lab reliability of each method SECONDARY OBJECTIVES * To assess the ability of the network of sites to efficiently conduct a study involving biosample collection for PD research. Efficiency will be assessed using measures of the time taken to meet specific milestones within the study * To assess the ability of the network to collect high quality biospecimens adhering to agreed-upon protocols. * To gauge the willingness of participants to participate in subsequent Fox BioNet studies
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Lumbar Puncture | Lumbar Puncture for collection of Cerebrospinal Fluids |
Timeline
- Start date
- 2019-04-23
- Primary completion
- 2019-12-18
- Completion
- 2019-12-18
- First posted
- 2018-12-14
- Last updated
- 2021-09-08
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03775447. Inclusion in this directory is not an endorsement.